Nuclear Medicine Market Expected to Reach USD 18.87 Bn by 2030, 14.7% CAGR - Digirad Corporation, CMR Naviscan Drive Market Expansion


Posted February 14, 2024 by krajput

Nuclear Medicine Market: Global Industry Analysis and Forecast (2024-2030)

 
Nuclear Medicine Market to Boom at 14.7% CAGR, Reaching $18.87 Billion by 2030: Key Players Drive Growth
Market Overview:

The global Nuclear Medicine market is poised for significant expansion, surging from USD 7.22 billion in 2023 to USD 18.87 billion by 2030, at a robust CAGR of 14.7%. This growth is driven by rising demand for accurate and minimally invasive diagnoses and treatments, alongside an aging population susceptible to chronic diseases.

To access the sample report, please click here: https://www.maximizemarketresearch.com/request-sample/98418

Report Scope:

This comprehensive report offers in-depth insights into the Nuclear Medicine market, including:

Market size and growth projections: Historical data (2017-2023) and forecasts (2024-2030)
Segmentation: By product type (diagnostic, therapeutic), application (neurology, oncology, cardiology), modality (SPECT, PET), and end-user (hospitals, diagnostic centers)
Competitive landscape: Profiles of key players and their strategies
Research methodology: Detailed explanation of data collection and analysis methods
Regional insights: Growth trends and opportunities in North America, Europe, Asia Pacific, Middle East & Africa, and South America
Market Dynamics:

Key drivers fueling market growth include:

Increased prevalence of chronic diseases: Rising incidence of cancer, cardiovascular disorders, and neurological conditions drives demand for diagnostics and targeted therapies.
Advancements in technology: Development of high-resolution imaging systems, targeted radiopharmaceuticals, and hybrid modalities like SPECT-CT and PET-CT improves diagnosis and treatment accuracy.
Growing awareness and adoption: Expanding healthcare infrastructure, government initiatives, and rising awareness about Nuclear Medicine benefits fuel market growth.
Consolidation Trends:

The market is witnessing growing consolidation through mergers, acquisitions, and partnerships among industry players. This trend aims to expand product portfolios, geographical reach, and R&D capabilities.

Research Methodology:

This report leverages a combination of primary and secondary research methodologies:

Primary research: Surveys and interviews with industry experts, key players, and healthcare professionals.
Secondary research: Analysis of published reports, government data, and industry publications.
Segmentation and Regional Insights:

By product type: The diagnostic segment holds the largest share due to its widespread use in early disease detection. The therapeutic segment is expected to witness the highest growth due to the development of innovative radiopharmaceuticals.

By application: Oncology dominates the market, followed by cardiology and neurology. Emerging applications like personalized medicine and theranostics offer significant growth potential.

By region: North America leads the market due to advanced healthcare infrastructure and high adoption of Nuclear Medicine procedures. Asia Pacific is expected to exhibit the fastest growth rate due to its expanding population and increasing healthcare investments.

Nuclear Medicine Market, Key Players are:

1. Cardinal Health Inc (US)
2. GE HealthCare Technologies Inc (US)
3. Jubliant Lifesciences (US)
4. Lantheus Medical Imaging Inc. (US)
5. Biodex Medical Systems, Inc. (US)
6. Standard Imaging Inc. (US)
7. Digirad Corporation (US)
8. CMR Naviscan (US)
9. Nordion Inc. (Canada)
10. Bayer AG (Germany)
11. Siemens Healthineers (Germany)
12. SurgicEye GmbH (Germany)
13. Curium (France)
14. Advanced Accelerator Applications (France)
15. Mallinckrodt Pharmaceuticals (UK)
16. Bartec Technologies Ltd. (UK)
17. Norgine B.V. (Netherland)
18. Medtronic plc (Ireland)
19. DDD-Diagnostic A/S (Denmark)
20. Mediso Ltd. (Hungary)
21. Neusoft Corporation (China)
22. Canon Medical Systems Corporation (Japan)
23. FUJIFILM Holdings Corporation (Japan)
24. Cyclopharm (Australia)
25. Bozlu Holding A.Ş (Turkey)

Conclusion:

The Nuclear Medicine market presents a promising future with numerous growth opportunities fueled by technological advancements, rising healthcare needs, and increasing awareness. Strategic investments in R&D, regional expansion, and collaborations will be crucial for market players to capitalize on this expanding landscape.

The research report offers a detailed analysis of the Nuclear Medicine Market, providing valuable insights into market dynamics and growth prospects for the forecast period: https://www.maximizemarketresearch.com/market-report/global-nuclear-medicine-market/98418/

About Maximize Market Research:

At Maximize Market Research, our distinctive identity is founded on an unwavering commitment to excellence and innovation, steered by a team of seasoned professionals with a rich blend of industry knowledge. Our expertise spans meticulously researched insights, thorough technological analyses, and strategic guidance derived from comprehensive evaluations of competitive landscapes. Grounded in the principles of adaptability and innovation, we stand as a beacon at the forefront of industry trends. Our commitment is not static but dynamic, continuously evolving to meet the unique and evolving needs of our clients, ensuring that our services remain cutting-edge in an ever-changing business landscape. This steadfast commitment positions us as trailblazers, adeptly navigating clients through the challenges of a dynamically evolving market and fortifying our leadership position. Central to our enduring dedication is the drive to propel success for our clients, not merely by meeting expectations but by delivering unparalleled value. Embracing a proactive approach to market dynamics, we anticipate shifts and trends, ensuring our clients are well-prepared for the future. Moreover, our commitment extends beyond immediate gains, emphasizing the cultivation of long-term partnerships. By fostering strong, enduring relationships, we aim to be more than service providers; we aspire to be trusted allies in our clients' journey towards sustained success in an ever-changing business landscape.

Contact Maximize Market Research:

Maximize Market Research Pvt. Ltd.
📍 3rd Floor, Navale IT Park Phase 2,
Pune Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.

📞 +91 9607365656
📧 [email protected]
🌐 www.maximizemarketresearch.com

Explore more related reports:

Steel Long Products Market https://www.maximizemarketresearch.com/market-report/steel-long-products-market/188895/

Catalyst Regeneration Market https://www.maximizemarketresearch.com/market-report/global-catalyst-regeneration-market/27353/

Automotive Energy Recovery Systems Market https://www.maximizemarketresearch.com/market-report/automotive-energy-recovery-systems-market/11088/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MMR
Phone 09607365656
Business Address 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India.
Country India
Categories Advertising
Tags nuclear medicine market , nuclear medicine market size
Last Updated February 14, 2024